These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26476081)

  • 1. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
    Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP
    Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice.
    Zhang L; Liu Y; Wang X; Tang Z; Li S; Hu Y; Zong X; Wu X; Bu Z; Wu A; Li Z; Li Z; Huang X; Jia L; Kang Q; Liu Y; Sutton D; Wang L; Luo L; Ji J
    Sci Rep; 2015 Mar; 5():9447. PubMed ID: 25819560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
    Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
    Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
    PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
    Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
    Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patient‑derived xenograft models.
    Kalavska K; Kucerova L; Schmidtova S; Toro L; Kozovska Z; Plank L; Chovanec M; Palacka P; Pindak D; Macak D; Mardiak J; Mego M
    Oncol Rep; 2018 Dec; 40(6):3593-3602. PubMed ID: 30542732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
    Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
    Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.
    Wetterauer C; Vlajnic T; Schüler J; Gsponer JR; Thalmann GN; Cecchini M; Schneider J; Zellweger T; Pueschel H; Bachmann A; Ruiz C; Dirnhofer S; Bubendorf L; Rentsch CA
    Prostate; 2015 May; 75(6):585-92. PubMed ID: 25585936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transformation of patient-derived tumor xenografts into lymphomas: characteristics, influence factors and precautions].
    Zou J; Gao J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):833-7. PubMed ID: 27452762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.
    Shi J; Li Y; Jia R; Fan X
    Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.
    Luo M; He Y; Xie B; Li S; Gan F; Zhang S; Luo P
    Pediatr Surg Int; 2021 Aug; 37(8):1031-1040. PubMed ID: 34031745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
    Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
    J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenograft models for the study of benign human neoplasms.
    de Souza JC; Miguita L; Gomez RS; Gomes CC
    Exp Mol Pathol; 2021 Jun; 120():104630. PubMed ID: 33744281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
    Yao LC; Aryee KE; Cheng M; Kaur P; Keck JG; Brehm MA
    Methods Mol Biol; 2019; 1953():241-252. PubMed ID: 30912026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Dieter SM; Giessler KM; Kriegsmann M; Dubash TD; Möhrmann L; Schulz ER; Siegl C; Weber S; Strakerjahn H; Oberlack A; Heger U; Gao J; Hartinger EM; Oppel F; Hoffmann CM; Ha N; Brors B; Lasitschka F; Ulrich A; Strobel O; Schmidt M; von Kalle C; Schneider M; Weichert W; Ehrenberg KR; Glimm H; Ball CR
    Int J Cancer; 2017 Mar; 140(6):1356-1363. PubMed ID: 27935045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
    Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
    Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.